Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of leucovorin rescue with pralatrexate in relapsed/refractory PTCL (Japan)
jRCT2080224048Phase 2Completed
- Sponsor
- Mundipharma
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of folinic acid and pralatrexate in peripheral T-cell lymphoma (PTCL), sponsored by Mundipharma. Started Sep 2018; status: completed.
02
Drugs
folinic acidpralatrexate
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on jRCT2080224048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224048.